Analysis
Members compared
All roll calls · whole term, 16 Jul 2024 – 1 Oct 2026 · Barry ANDREWS, Manfred WEBER, Jordan BARDELLA · abstentions counted
How often did these members vote the same way — against the usual agreement between their groups — and on which votes did they differ?
Members compared
Two to six members. Search by name and tick the ones to add, or tick members in the member register and choose Compare.
- Barry ANDREWS Renew · IE Remove
- Manfred WEBER EPP · DE Remove
- Jordan BARDELLA Patriots · FR Remove
The members, 3
Group now (or on the last day in office); ⇄ marks a change of group during the term.
- Barry ANDREWS Renew · Ireland
- Manfred WEBER EPP · Germany
- Jordan BARDELLA Patriots · France
Agreement, pair by pair, 3
Each pair: of the votes both cast a position in, the share where they voted the same way.
| Members | Agreement | Same position | Shared votes | Baseline |
|---|---|---|---|---|
| Barry ANDREWS and Manfred WEBER | 81.1 % | 3 266 | 4 025 | 81.6 % |
| Barry ANDREWS and Jordan BARDELLA | 26.5 % | 1 108 | 4 184 | 29.2 % |
| Manfred WEBER and Jordan BARDELLA | 34.1 % | 1 341 | 3 933 | 37.1 % |
Where they differed, 3 683
Votes where the members did not all cast the same position, newest first. “No vote” is a vote they did not record — not necessarily an absence.
| Vote | Barry ANDREWS | Manfred WEBER | Jordan BARDELLA |
|---|---|---|---|
| 20 Jan 2026 Amendment 33 to paragraph 2 The 28th Regime: a new legal framework for innovative companies | Against | Against | For |
| 20 Jan 2026 Final vote Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest | For | For | Abstained |
| 20 Jan 2026 Amendment 256, adding text after recital 12 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest | For | Against | For |
| 20 Jan 2026 Amendment 259 to recital 4 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest | Against | Against | For |
| 20 Jan 2026 Amendment 244, adding text after recital 3 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest | For | Against | Abstained |
| 20 Jan 2026 Amendment 187 to Article 23 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest | For | For | Against |
| 20 Jan 2026 Amendment 178 to Article 22 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest | For | For | Against |
| 20 Jan 2026 Amendment 170 to Article 21 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest | For | For | Against |
| 20 Jan 2026 Amendment 257 to Article 3, paragraph 1, point 5 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest | For | Against | For |
| 20 Jan 2026 Amendment 164 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest | For | For | Against |
| 20 Jan 2026 Amendment 163 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest | For | For | Against |
| 20 Jan 2026 Amendment 162 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest | For | For | Against |
| 20 Jan 2026 Amendment 159 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest | For | For | Against |
| 20 Jan 2026 Amendment 158 Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest | For | For | Against |
| 17 Dec 2025 Final vote — text as a whole (B10-0558/2025) European Citizens’ Initiative ‘My voice, my choice: for safe and accessible abortion’ | No vote recorded | Against | Abstained |
| 17 Dec 2025 Separate vote on recital R European Citizens’ Initiative ‘My voice, my choice: for safe and accessible abortion’ | No vote recorded | For | Against |
| 17 Dec 2025 Amendment 6 to recital N European Citizens’ Initiative ‘My voice, my choice: for safe and accessible abortion’ | No vote recorded | Against | For |
| 17 Dec 2025 Recital J — part 2 European Citizens’ Initiative ‘My voice, my choice: for safe and accessible abortion’ | No vote recorded | For | Abstained |
| 17 Dec 2025 Recital E — part 2 European Citizens’ Initiative ‘My voice, my choice: for safe and accessible abortion’ | No vote recorded | For | Against |
| 17 Dec 2025 Amendment 3 to recital E European Citizens’ Initiative ‘My voice, my choice: for safe and accessible abortion’ | No vote recorded | Against | For |
| 17 Dec 2025 Separate vote on paragraph 9 European Citizens’ Initiative ‘My voice, my choice: for safe and accessible abortion’ | No vote recorded | Against | For |
| 17 Dec 2025 Separate vote on paragraph 7 European Citizens’ Initiative ‘My voice, my choice: for safe and accessible abortion’ | No vote recorded | Against | For |
| 17 Dec 2025 Amendment 10 to paragraph 5 European Citizens’ Initiative ‘My voice, my choice: for safe and accessible abortion’ | No vote recorded | Against | For |
| 17 Dec 2025 Amendment 9 to paragraph 2 European Citizens’ Initiative ‘My voice, my choice: for safe and accessible abortion’ | No vote recorded | Against | For |
| 17 Dec 2025 Final vote — text as a whole Digitalisation, artificial intelligence and algorithmic management in the workplace – shaping the future of work | No vote recorded | For | Abstained |
| 17 Dec 2025 Final vote Digitalisation, artificial intelligence and algorithmic management in the workplace – shaping the future of work | No vote recorded | For | Against |
| 17 Dec 2025 Final vote Digitalisation, artificial intelligence and algorithmic management in the workplace – shaping the future of work | No vote recorded | For | Abstained |
| 17 Dec 2025 Paragraph 27 — part 2 Digitalisation, artificial intelligence and algorithmic management in the workplace – shaping the future of work | No vote recorded | For | Abstained |
| 17 Dec 2025 Paragraph 16 — part 2 Digitalisation, artificial intelligence and algorithmic management in the workplace – shaping the future of work | No vote recorded | For | Against |
| 17 Dec 2025 Paragraph 7 — part 2 Digitalisation, artificial intelligence and algorithmic management in the workplace – shaping the future of work | No vote recorded | For | Against |
| 17 Dec 2025 Final vote on the motion for a resolution Military Mobility | No vote recorded | For | Against |
| 17 Dec 2025 Final vote on the provisional agreement Phasing out Russian natural gas imports, improving monitoring of potential energy dependencies | No vote recorded | For | Against |
| 17 Dec 2025 Proposal to reject the text Phasing out Russian natural gas imports, improving monitoring of potential energy dependencies | No vote recorded | Against | For |
| 16 Dec 2025 Final vote on the motion for a resolution Genetically modified sugar beet KWS20-1 | No vote recorded | Against | For |
| 16 Dec 2025 Final vote on the motion for a resolution Genetically modified maize NK603 | No vote recorded | Against | For |
| 16 Dec 2025 Amendment 1 to paragraph 6 Relations between the EU and Saudi Arabia | No vote recorded | Against | Abstained |
| 16 Dec 2025 Amendment 11, adding text after recital E Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/003 SE/Northvolt – Sweden | No vote recorded | Against | For |
| 16 Dec 2025 Amendment 3 to Article 15 Compulsory licensing of patents in crisis situations | No vote recorded | Against | For |
| 16 Dec 2025 Amendment 2 to Article 5 Compulsory licensing of patents in crisis situations | No vote recorded | Against | For |
| 16 Dec 2025 Amendment 1, adding text after Article 4; Regulation (EC) No 816/2006 Compulsory licensing of patents in crisis situations | No vote recorded | Against | For |
| 16 Dec 2025 Amendment 1, adding text after recital 14 Amending the Directive on alternative dispute resolution for consumer disputes | No vote recorded | Against | For |
| 16 Dec 2025 Final vote Bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur Interim Trade Agreement for agricultural products | No vote recorded | For | Against |
| 16 Dec 2025 Amendment 39 to recital 4 Bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur Interim Trade Agreement for agricultural products | No vote recorded | Against | For |
| 16 Dec 2025 Amendment 69, adding text after recital 2 Bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur Interim Trade Agreement for agricultural products | No vote recorded | Against | For |
| 16 Dec 2025 Amendment 81 to recital 2 Bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur Interim Trade Agreement for agricultural products | No vote recorded | Against | For |
| 16 Dec 2025 Amendment 18 to recital 2 Bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur Interim Trade Agreement for agricultural products | No vote recorded | Against | For |
| 16 Dec 2025 Amendment 52 to recital 2 Bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur Interim Trade Agreement for agricultural products | No vote recorded | Against | For |
| 16 Dec 2025 Amendment 71, adding text after Article 19 Bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur Interim Trade Agreement for agricultural products | No vote recorded | Against | For |
| 16 Dec 2025 Amendment 67 to Article 14 Bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur Interim Trade Agreement for agricultural products | No vote recorded | Against | For |
| 16 Dec 2025 Amendment 51 to Article 14 Bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur Interim Trade Agreement for agricultural products | No vote recorded | Against | For |
About these figures
What was counted, what was left out, and how.
- 5 928 votes considered (all roll-call votes matching the filters; scope).
- 174 of 794 decisions in the period had no final vote recorded by name (a show of hands or a count without names) and cannot be measured.
- Each member is counted in the group they belonged to on the day of the vote (group at the date).
- Roll calls are not a random sample: final votes on laws are recorded by name, most other roll calls because a group asked for it. A group’s line is inferred from its members’ votes; the Parliament publishes no whip.
- Methods: Agreement between two members v1, Final votes and all roll calls v1, Group at the date of the vote v1.
- Data as of 1 Oct 2026, 03:37 UTC (data stamp 7669c786bb14, code 6d4005c55bde; what the stamp is).
Sources & citation
Where the facts on this page come from, and how to cite it.
- Data source
- Licensed CC BY 4.0.
- Data version
- data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
- Retrieved
- 1 October 2026
Cite as
EU Parl Watch Research (2026). “Members compared — All roll calls · whole term, 16 Jul 2024 – 1 Oct 2026 · Barry ANDREWS, Manfred WEBER, Jordan BARDELLA · abstentions counted”. Analysis. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/analysis/members?ids=204332%2C28229%2C131580&scope=all&to=2026-10-01 (retrieved 1 October 2026). Data: European Parliament Open Data, https://data.europarl.europa.eu/ (CC BY 4.0); data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-analysis-2026-10-01,
author = {{EU Parl Watch Research}},
title = {{Members compared — All roll calls · whole term, 16 Jul 2024 – 1 Oct 2026 · Barry ANDREWS, Manfred WEBER, Jordan BARDELLA · abstentions counted}},
year = {2026},
howpublished = {\url{https://news.eu-parl.st-solutions.dev/analysis/members?ids=204332%2C28229%2C131580&scope=all&to=2026-10-01}},
url = {https://news.eu-parl.st-solutions.dev/analysis/members?ids=204332%2C28229%2C131580&scope=all&to=2026-10-01},
urldate = {2026-10-01},
publisher = {EU Parl Watch Research},
note = {Analysis. Data: European Parliament Open Data (CC BY 4.0); data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}